Patents Represented by Attorney Keroy Whitacker
  • Patent number: 5254582
    Abstract: This invention provides the use of N-[[(3,4-dichlorophenyl)amino]carbonyl]-2,3-dihydrobenzofuran-5-sulfonamid e, and pharmaceutically acceptable salts thereof, in the treatment of susceptible neoplasms in mammals. This invention further provides the novel aforementioned compound and its pharmaceutical formulations.
    Type: Grant
    Filed: February 5, 1992
    Date of Patent: October 19, 1993
    Assignee: Eli Lilly and Company
    Inventors: George B. Boder, William J. Ehlhardt, Gerald B. Grindey, John E. Toth, John F. Worzalla, John L. Zimmermann